A-Alpha Bio Awarded $800K to Develop Infectious Disease Drugs using...

Supported by the Bill & Melinda Gates Foundation, A-Alpha Bio and Lumen Bioscience will Leverage AlphaSeq Data to Optimize Therapeutic Antibodies with Machine Learning(PRWeb July 09, 2020)Read the full story at https://www.prweb.com/releases/a_alpha_bio_awarded_800k_to_develop_infectious_disease_drugs_using_alphaseq_platform/prweb17246675.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news